About Parallaxis

Vision

Parallaxis becomes the Proof Step in a reimagined Health & Wellness Marketing Mix.

Mission

Parallaxis unlocks the potential of Health & Wellness brands by strategically building and leveraging evidence that empowers consumer choice.

Why We Exist

Parallaxis was founded to support brands, products and ingredients navigate shifting consumer expectations, evidence generation requirements and regulatory frameworks.

We exist to help our clients cut through complexity by translating science into claims that are credible, regulatory aligned and commercially meaningful.

Founders

We started Parallaxis after seeing too many ambitious health & wellness brands with genuinely strong products held back by a lack of clarity in how to navigate shifting consumer expectations, evidence generation, claim substantiation and the regulatory frameworks they operate within.

We’ve each spent the last 20 years working across global pharmaceutical environments, where evidence is the currency — and where it clearly separates performance from non-performance, success from failure.

Andrew Charles

Co-Founder, Parallaxis

Paul Dunesky

Co-Founder, Parallaxis

What We Believe

Trust is earned through proof, not promises. Strong claims are built through evidence thresholds. Regulation and creativity can work together when risk is understood.

Insights

Evidence, claims and commercial thinking at the intersection of science and brand.

Three Routes to a Cosmetic Claim, And Why Two of Them Eat Your Margin

Two of the three routes to a cosmetic claim cost more than they should. A 3-minute read on AICIS, ACCC, and how to land on the route that compounds.

30 Apr 2026

min read

Evidence Strategy for Health Brands: Build the Map Before the Campaign

Gut health, longevity, neurowellness — three of the biggest wellness categories in 2026 all share the same problem: marketing language that has outrun the evidence. Here’s what evidence-first strategy looks like in practice.

17 Apr 2026

min read

Creatine’s Mainstream Moment: What It Teaches About Evidence Timing

The global creatine market hit $1.1B in 2024 — driven by brain health and women’s wellness, not just gym performance. We explore what this tells health brands about evidence timing and building defensible claims before the trend peaks.

17 Apr 2026

min read

Customer Testimonials

Reinforces trust, credibility and real-world impact.

No items found.

Vision

Mission

Why We Exist

Founders

What We Believe

Insights

Customer Testimonials

Start with the Right Questions